EUVIMEDEUVIMED entdecken
Crossref

Screening for sexually transmitted infections in the transgender population and interaction of gender-affirming hormonal treatment with antiretroviral therapy

Esteban Sánchez-Toscano, Dunia Collazo-Yáñez, Jesús Domínguez-Riscart, Laura Larrán-Escandón, Andrés Martín-Aspas, Isabel Mateo-Gavira, Manuel Aguilar-Diosdado

Enfermedades infecciosas y microbiologia clinica (English ed.) · 2025

DOI: 10.1016/j.eimce.2025.06.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Enfermedades infecciosas y microbiologia clinica (English ed.), 2025. Verfasst von Esteban Sánchez-Toscano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Endocrinología y Nutrición, Hospital Universitario Puerta del Mar, Cádiz, Spain; Instituto de Investigación e Innovación Biomédica de Cád…. Hauptthemen laut MEDLINE: Transgender Persons, Sexually Transmitted Diseases, Anti-Retroviral Agents, Gender-Affirming Procedures. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Current evidence suggests that transgender people have a higher risk of sexually transmitted infections (STIs) than general population, although most of the literature focuses on transwomen with HIV. OBJECTIVE: To determine the prevalence of STDs diagnosed by serology in transgender population in our hospital and to analyze the impact of antiretroviral treatment on hormonal therapy. METHODS: We design a cross-sectional study based on medical records of transgender people treated at the Transgender Care Unit of Cadiz from June 2022 to June 2023. Hepatitis, HIV and syphilis serology was requested from people between 16 and 65 years. RESULTS: A total of 295 people were included, 48,14% transwomen (n = 142) and 51,86% transmen (n = 153), with an average age of 24,78 ± 9,2 years. It was detected 14 cases of HAV, 5 of syphilis, 3 of HBV and 3 of HCV. Prevalence of HIV was 3,73% (n = 11). Of the 9 transwomen with HIV infection, 3 of them required a change in antiretroviral medication and 2 cases required changes in the route of estrogen administration to achieve optimal plasma hormone levels. CONCLUSIONS: With the current model of care for transgender people in Andalusia, the prevalence of STDs detected in our sociocultural environment is low. Special attention should be paid to possible interactions between antiretroviral treatment and hormone therapy, especially in transwomen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsSexually Transmitted DiseasesAnti-Retroviral AgentsGender-Affirming ProceduresHumansCross-Sectional StudiesFemaleAdultMaleMiddle AgedPrevalenceYoung AdultAgedAdolescentHIV Infections

Stichwörter der Autor:innen

Antiretroviral therapyGender-affirming hormonesHuman immunodeficiency virusInfecciones de transmisión sexualSexually transmitted infectionsTransgenderTransgéneroTratamiento antirretroviralTratamiento hormonal reafirmante de géneroVirus de la inmunodeficiencia humana

Substanzen

Anti-Retroviral Agents

Autor:innen und Institutionen

  • Servicio de Endocrinología y Nutrición, Hospital Universitario Puerta del Mar, Cádiz, Spain; Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA), Cádiz, Spain. Electronic address: estebansanchez1994@gma…
  • Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario Puerta del Mar, Cádiz, Spain.
  • Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA), Cádiz, Spain; Servicio de Pediatría y sus Áreas Específicas, Hospital Universitario Puerta del Mar, Cádiz, Spain.
  • Servicio de Endocrinología y Nutrición, Hospital Universitario Puerta del Mar, Cádiz, Spain.
  • Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA), Cádiz, Spain; Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario Puerta del Mar, Cádiz, Spain; Facultad de Medi…
  • Servicio de Endocrinología y Nutrición, Hospital Universitario Puerta del Mar, Cádiz, Spain; Instituto de Investigación e Innovación Biomédica de Cádiz (INiBICA), Cádiz, Spain.

Zitieren

APA

Sánchez-Toscano, E., Collazo-Yáñez, D., Domínguez-Riscart, J., Larrán-Escandón, L., Martín-Aspas, A., Mateo-Gavira, I., & Aguilar-Diosdado, M. (2025). Screening for sexually transmitted infections in the transgender population and interaction of gender-affirming hormonal treatment with antiretroviral therapy. Enfermedades infecciosas y microbiologia clinica (English ed.). https://doi.org/10.1016/j.eimce.2025.06.003

Vancouver

Sánchez-Toscano E, Collazo-Yáñez D, Domínguez-Riscart J, Larrán-Escandón L, Martín-Aspas A, Mateo-Gavira I, et al. Screening for sexually transmitted infections in the transgender population and interaction of gender-affirming hormonal treatment with antiretroviral therapy. Enfermedades infecciosas y microbiologia clinica (English ed.). 2025. doi:10.1016/j.eimce.2025.06.003

BibTeX
@article{SnchezToscano2025,
  author = {Sánchez-Toscano, Esteban and Collazo-Yáñez, Dunia and Domínguez-Riscart, Jesús and Larrán-Escandón, Laura and Martín-Aspas, Andrés and Mateo-Gavira, Isabel and Aguilar-Diosdado, Manuel},
  title = {Screening for sexually transmitted infections in the transgender population and interaction of gender-affirming hormonal treatment with antiretroviral therapy},
  journal = {Enfermedades infecciosas y microbiologia clinica (English ed.)},
  year = {2025},
  doi = {10.1016/j.eimce.2025.06.003}
}
Kostenlos starten →